The relationship among hypertension, antihypertensive medications, and osteoporosis: A narrative review

Calcified Tissue International

Volumn 92, Issue 3, 2013, Pages 217-227

  Ilić, Katarina ^a   Obradović, Nevena ^a   Vujasinović Stupar, Nada ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

ACE inhibitor; Antihypertensive; Beta blocker; Osteoporosis; Thiazide diuretic

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; PLACEBO; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BONE DENSITY; CALCIUM INTAKE; CHRONIC DRUG ADMINISTRATION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; FRACTURE; HUMAN; HYPERTENSION; NONHUMAN; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SODIUM INTAKE; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY;

EID: 84873706063     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-012-9671-9     Document Type: Review

References (58)

1. Pérez-Castrillón JL, Justo I, Sanz-Cantalapiedra A, Pueyo C, Hernández G, Dueñas A (2005) Effect of the antihypertensive treatment on the bone mineral density and osteoporotic fracture. Curr Hypertens Rev 1:61-66
2. Reginster JY, Burlet N (2006) Osteoporosis: a still increasing prevalence. Bone 38:S4-S9
3. European Society for Clinical and Economic Aspect of Osteoporosis and Osteoarthritis (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399-428
4. International Osteoporosis Foundation. Osteoporosis general. http://www.iofbonehealth.org/facts-and-statistics.html. Accessed 14 July 2009
5. Metz JA, Morris CD, Roberts LA, McClung MR, McCarron DA (1999) Blood pressure and calcium intake are related to bone density in adult males. Br J Nutr 81:383-388
6. Cappucio FP, Meilahn E, Zmuda JM, Cauley JA (1999) High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet 354:971-975
7. Vestergaard P, Rejnmark L, Mosekilde L (2009) Hypertension is a risk factor for fractures. Calcif Tissue Int 84:103-111
8. Rejnmark L, Vestergaard P, Mosekilde L (2006) Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens 24:581-589
9. Lynn H, Kwok T, Wong SYS, Woo J, Leung PC (2006) Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone 38:584-588
10. Ott SM, LaCroix AZ, Scholes D, Ichikawa L, Wu K (2008) Effects of three years of low-dose thiazides on mineral metabolism in healthy elderly persons. Osteoporos Int 19:1315-1322
11. Rang HP et al. (2012) Bone metabolism. In: Rang and Dale's pharmacology. 7th ed, Churchill Livingstone, Elsevier, Philadelphia, pp 432-441
12. Power ML, Heaney RP, Kalkwarf HJ et al (1999) The role of calcium in health and disease. Am J Obstet Gynecol 181:1560-1569
13. Zemel MB (2001) Calcium modulation of hypertension and obesity: mechanisms and implications. J Am Coll Nutr 20:428S-435S
14. McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR (2004) Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine 23(1):1-10
15. Zitterman A, Schleithoff SS, Koerfer R (2005) Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 94:483-492
16. Lips P (2006) Vitamin D physiology. Prog Biophys Mol Biol 92:4-8
17. Boonen S, Vanderschueren D, Haentjens P, Lips P (2006) Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update. J Intern Med 259:539-552
18. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H et al (2000) Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 66(6):419-424
19. Mosekilde L (2005) Vitamin D and the elderly. Clin Endocrinol (Oxf) 62:265-281
20. London GM, Guérin AP, Verbeke FH et al (2007) Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18:613-620
21. 1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int 73:21-26
22. Vermeer C, Shearer M, Zittermann A et al (2004) Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr 43:325-335
23. 2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 18:963-972
24. Anagnostis P, Karagiannis A, Kakafika AI, Tziomalos K, Athyros VG, Mikhailidis DP (2009) Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? Osteoporos Int 20:197-207
25. Cranenburg CME, Schurgers JL, Vermeer C (2007) Vitamin K: The coagulation vitamin that became omnipotent. Thromb Haemost 98:120-125
26. Adams J, Pepping J (2005) Vitamin K in the treatment and prevention of osteoporosis and arterial calcification. Am J Health Syst Pharm 62
27. Cockayne S, Adamson J, Lanham-New S, Shearer M, Gilbody S, Torgerson D (2006) Vitamin K and the prevention of fractures - systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 166:1256-1261
28. Heaney PR (2006) Role of dietary sodium in osteoporosis. J Am Coll Nutr 25(3):271S-276S
29. Woo J, Kwok T, Leung J, Tang N (2009) Dietary intake, blood pressure and osteoporosis. J Hum Hypertens 23:451-455
30. Karppanen H, Karppanen P, Mervaala E (2005) Why and how to implement sodium, potassium, calcium, and magnesium changes in food items and diets? J Hum Hypertens 19:S10-S19
31. Rang HP et al. (2012) The vascular system. In: Rang and Dale's Pharmacology. 7th ed, Churchill Livingstone, Elsevier, Philadelphia, pp 265-282
32. Khosla S (2011) Is nitroglycerin a novel and inexpensive treatment for osteoporosis? JAMA 305(8):826-827
33. Jamal SA, Hamilton CJ, Eastell R, Cummings SR (2011) Effect of nitroglycerin ointment on bone density and strength in postmenopausal women. JAMA 05(8):800-807
34. Rejnmark L, Vestergaard P, Mosekilde L (2006) Decreased fracture risk in users of organic nitrates: a nationwide case-control study. J Bone Miner Res 21(11):1811-1817
35. Wimalawansa SJ (2000) Nitroglycerin therapy is as efficacious as standard estrogen replacement therapy (Premarin) in prevention of oophorectomy-induced bone loss: a human pilot clinical study. J Bone Miner Res 15(11):2240-2244
36. Wimalawansa SJ, Grimes JP, Wilson AC, Hoover DR (2009) Transdermal nitroglycerin therapy may not prevent early postmenopausal bone loss. J Clin Endocrinol Metab 94(9):3356-3364
37. Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E, Nicholson GC (2004) Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong osteoporosis study. J Bone Miner Res 19:19-24
38. Shih TTF, Chang CJ, Tseng WYI et al (2004) Effect of calcium channel blockers on vertebral bone marrow perfusion of the lumbar spine. Radiology 231:24-30
39. Žofkova I, Kancheva RL (1995) The effect of nifedipine on serum parathyroid hormone and calcitonin in postmenopausal women. Life Sci 57(11):1087-1096
40. Rejnmark L, Vestergaard P, Mosekilde L (2006) Fracture risk in patients treated with loop diuretics. J Intern Med 259:117-124
41. Rejnmark L, Vestergaard P, Kassem M et al (2004) Fracture risk in perimenopausal women treated with beta-blockers. Calcif Tissue Int 75:365-372
42. Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L (2006) Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. J Bone Miner Res 21:163-170
43. Reid IR, Gamble GD, Grey AB et al (2005) β-blocker use, BMD, and fractures in the study of osteoporotic fractures. J Bone Miner Res 20:613-618
44. Zacharieva S, Shigarminova R, Nachev E et al (2003) Effect of amlodipine and hormone replacement therapy on blood pressure and bone markers in menopause. Methods Find Exp Clin Pharmacol 25(3):209
45. Hajjar I (2005) Postural blood pressure changes and orthostatic hypotension in the elderly patient: impact of antihypertensive medications. Drugs Aging 22(1):55-68
46. Sowers MR, Clark MK, Jannausch ML, Wallace RB (1993) Body size, estrogen use and thiazide diuretic use affect 5-year radial bone loss in postmenopausal women. Osteoporos Int 3:314-321
47. Cauley JA, Cummings SR, Seeley DG et al (1993) Effects of thiazide diuretic therapy on bone mass, fractures, and falls. Ann Intern Med 118:666-673
48. Jones G, Nguyen Tuan, Sambrook PN, Eisman JA (1995) Thiazide diuretics and fractures: can meta-analysis help? J Bone Miner Res 10:106-111
49. LaCroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE (2000) Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 133:516-526
50. Schoofs MWCJ, van der Klift M, Hofman A et al (2003) Thiazide diuretics and the risk for hip fracture. Ann Intern Med 139:476-482
51. Bolland MJ, Ames RW, Horne AM, Orr-Walker BJ, Gamble GD, Reid IR (2007) The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int 18:479-486
52. Cruz DN (2001) The renal tubular Na-Cl co-transporter (NCCT): a potential genetic link between blood pressure and bone density? Nephrol Dial Transpl 16:691-694
53. Alkalosis, metabolic. http://emedicine.medscape.com/article/906819- overview. Accessed 24 Oct 2009
54. Haque SF, Ahmad M, Khan AU, Gupta V, Khan AS (2011) Angiotensin converting enzyme insertion/deletion gene polymorphism and genomic sequence in diabetic nephropathy. Biomed Res 22(2):173-177
55. Schlienger RG, Kraenzlin ME, Jick SS, Meier CR (2004) Use of β-blockers and risk of fractures. JAMA 292:1326-1332
56. Takeda S (2009) Osteoporosis: a neurosceletal disease? Int J Biochem Cell Biol 41:455-459
57. Wiens M, Etminan M, Gill SS, Takkouche B (2006) Effects of antihypertensive drug treatment on fracture outcomes: a meta-analysis of observational studies. J Intern Med 260:350-362
58. Souverein PC, Van Staa TP, Egberts ACG, de la Rosette MCH, Cooper C, Leufkens HGM (2003) Use of α-blockers and the risk of hip/femur fractures. J Intern Med 254:548-554